Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 11 studies | 20% ± 5% | |
plasma cell | 8 studies | 24% ± 9% | |
memory B cell | 8 studies | 18% ± 1% | |
endothelial cell | 8 studies | 22% ± 4% | |
macrophage | 8 studies | 23% ± 7% | |
classical monocyte | 7 studies | 24% ± 10% | |
plasmacytoid dendritic cell | 7 studies | 23% ± 5% | |
epithelial cell | 4 studies | 21% ± 4% | |
ciliated cell | 4 studies | 22% ± 1% | |
oligodendrocyte | 4 studies | 20% ± 2% | |
conventional dendritic cell | 3 studies | 36% ± 15% | |
non-classical monocyte | 3 studies | 32% ± 8% | |
plasmablast | 3 studies | 29% ± 9% | |
platelet | 3 studies | 20% ± 3% | |
fibroblast | 3 studies | 18% ± 3% | |
monocyte | 3 studies | 19% ± 4% | |
glutamatergic neuron | 3 studies | 24% ± 7% | |
dendritic cell | 3 studies | 33% ± 18% | |
microglial cell | 3 studies | 23% ± 6% | |
naive B cell | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4801.80 | 1445 / 1445 | 100% | 14.74 | 183 / 183 |
uterus | 100% | 3827.59 | 170 / 170 | 100% | 24.39 | 459 / 459 |
thymus | 100% | 3747.97 | 653 / 653 | 100% | 25.96 | 604 / 605 |
lung | 100% | 4843.57 | 578 / 578 | 100% | 23.30 | 1153 / 1155 |
stomach | 100% | 3157.04 | 359 / 359 | 100% | 16.74 | 285 / 286 |
breast | 100% | 4214.73 | 459 / 459 | 100% | 20.37 | 1114 / 1118 |
prostate | 100% | 3064.51 | 244 / 245 | 100% | 21.93 | 502 / 502 |
skin | 100% | 3419.19 | 1801 / 1809 | 100% | 41.20 | 472 / 472 |
liver | 100% | 2013.22 | 225 / 226 | 100% | 16.95 | 406 / 406 |
pancreas | 100% | 2520.52 | 328 / 328 | 99% | 21.89 | 177 / 178 |
intestine | 100% | 4990.33 | 966 / 966 | 99% | 17.57 | 524 / 527 |
kidney | 100% | 2868.10 | 89 / 89 | 99% | 19.15 | 895 / 901 |
brain | 99% | 2365.73 | 2622 / 2642 | 100% | 23.01 | 705 / 705 |
ovary | 100% | 2346.89 | 180 / 180 | 99% | 16.36 | 425 / 430 |
bladder | 100% | 3782.10 | 21 / 21 | 99% | 17.60 | 497 / 504 |
adrenal gland | 100% | 1959.36 | 258 / 258 | 97% | 14.45 | 222 / 230 |
adipose | 100% | 4585.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 48.77 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 47.39 | 29 / 29 |
muscle | 100% | 3504.24 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5528.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.81 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.79 | 1 / 1 |
blood vessel | 100% | 4077.30 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 3170.82 | 858 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 5392.13 | 902 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050860 | Biological process | negative regulation of T cell receptor signaling pathway |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0007165 | Biological process | signal transduction |
GO_0050868 | Biological process | negative regulation of T cell activation |
GO_0051895 | Biological process | negative regulation of focal adhesion assembly |
GO_0035335 | Biological process | peptidyl-tyrosine dephosphorylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0016311 | Biological process | dephosphorylation |
GO_0002710 | Biological process | negative regulation of T cell mediated immunity |
GO_1903996 | Biological process | negative regulation of non-membrane spanning protein tyrosine kinase activity |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0031941 | Cellular component | filamentous actin |
GO_0005886 | Cellular component | plasma membrane |
GO_0061851 | Cellular component | leading edge of lamellipodium |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0004726 | Molecular function | non-membrane spanning protein tyrosine phosphatase activity |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0008138 | Molecular function | protein tyrosine/serine/threonine phosphatase activity |
GO_1990782 | Molecular function | protein tyrosine kinase binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | DUSP22 |
Protein name | Dual specificity phosphatase 22 Dual specificity protein phosphatase 22 (EC 3.1.3.16) (EC 3.1.3.48) (JNK-stimulatory phosphatase-1) (JSP-1) (Low molecular weight dual specificity phosphatase 2) (LMW-DSP2) (Mitogen-activated protein kinase phosphatase x) (MAP kinase phosphatase x) (MKP-x) |
Synonyms | JSP1 LMWDSP2 MKPX |
Description | FUNCTION: Activates the Jnk signaling pathway. . |
Accessions | ENST00000603453.5 ENST00000603296.5 ENST00000344450.9 [Q9NRW4-1] S4R3A4 S4R3K1 S4R3M1 ENST00000419235.7 [Q9NRW4-2] Q9NRW4 S4R378 ENST00000605863.5 ENST00000604971.5 S4R459 ENST00000603726.5 ENST00000603881.5 ENST00000603795.5 ENST00000605315.5 ENST00000605035.5 |